Maitane Andión Catalán
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Maitane Andión Catalán has a total of 31 co-authors. Here are the top co-authors by number of shared publications:
L. Madero López
3 shared publicationsD. Ruano Domínguez
2 shared publicationsA. Lassaletta Atienza
1 shared publication- Adela Cañete
Hospital Universitario y Politècnico La Fe, 46026 Valencia, Spain
1 shared publication - Alberto Moreno Vega
Medical Oncology Department, Hospital Universitario Virgen del Rocio, Seville, Spain
1 shared publication Ana Castillo Robleda
Servicio de Análisis Clínicos, Hospital Infantil Universitario Niño Jesús, Madrid, España
1 shared publication
Latest Publications
- Open Access
- 4 September 2025
- Published by Springer Nature in Clinical and Translational Oncology
- Vol. 28 (3) , 860-879
Management of late toxicities and specific follow-up needs of adolescent and young adult cancer survivors: recommendations from scientific societies in Spain
Adolescent and young adult cancer survivors (AYACS) represent a specific cancer patient population with unique chronic health issues difficult to identify in early, reversible phases with standard monitoring protocols. This review, conducted by a group of Spanish experts, provides recommendations for managing AYACS, focusing on key areas, such as cardiac toxicities, neurotoxicity and neurocognitive disorders, metabolic syndrome, secondary primary malignancies, bone toxicities, sexuality and fertility, psychosocial aspects, and other treatment-related toxicities.
- 4 September 2025
- Published by Springer Nature in Clinical and Translational Oncology
- Vol. 28 (3) , 860-879
Open AccessManagement of late toxicities and specific follow-up needs of adolescent and young adult cancer survivors: recommendations from scientific societies in Spain
Adolescent and young adult cancer survivors (AYACS) represent a specific cancer patient population with unique chronic health issues difficult to identify in early, reversible phases with standard monitoring protocols. This review, conducted by a group of Spanish experts, provides recommendations for managing AYACS, focusing on key areas, such as cardiac toxicities, neurotoxicity and neurocognitive disorders, metabolic syndrome, secondary primary malignancies, bone toxicities, sexuality and fertility, psychosocial aspects, and other treatment-related toxicities.
- Open Access
- 1 February 2020
- Published by Elsevier in Anales de Pediatría
- Vol. 92 (2) , 106-108
Infiltración cutánea como manifestación de leucemia congénita: presentación de 2 casos
- 1 February 2020
- Published by Elsevier in Anales de Pediatría
- Vol. 92 (2) , 106-108
Open AccessInfiltración cutánea como manifestación de leucemia congénita: presentación de 2 casos
- 1 October 2015
- Published by Elsevier in Anales de Pediatría (English Edition)
- Vol. 83 (4) , 279-280
Gastrointestinal involvement in Langerhans cell histiocytosis
- 1 October 2015
- Published by Elsevier in Anales de Pediatría (English Edition)
- Vol. 83 (4) , 279-280
Gastrointestinal involvement in Langerhans cell histiocytosis
- 1 October 2015
- Published by Elsevier in Anales de Pediatría
- Vol. 83 (4) , 279-280
Histiocitosis de células de Langerhans con afectación gastrointestinal
- 1 October 2015
- Published by Elsevier in Anales de Pediatría
- Vol. 83 (4) , 279-280
Histiocitosis de células de Langerhans con afectación gastrointestinal
- 1 June 2015
- Published by Elsevier in Anales de Pediatría (English Edition)
- Vol. 82 (6) , 381-387
Non-Hodgkin lymphoma: Excellent results at the expense of the high toxicity of the treatment
- 1 June 2015
- Published by Elsevier in Anales de Pediatría (English Edition)
- Vol. 82 (6) , 381-387
Non-Hodgkin lymphoma: Excellent results at the expense of the high toxicity of the treatment